Brainstorm Cell TherapeuticsBCLI
13F holders, Q3 2024 (September 30)4holders
$0.23avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Brainstorm Cell Therapeutics (BCLI) in their 13F filings. The largest holders were Abner Herrman & Brock LLC ($34K), Avior Wealth Management, LLC ($3K) and St Germain D J Co. Inc. ($115).
- Company
- Brainstorm Cell Therapeutics
- CUSIP
- 10501E300
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $37K |
| Exits | 0 | $0 |
Ownership 4 holders
| Abner Herrman & Brock LLC | 0.00% | New | 145,500 | $34K |
| Avior Wealth Management, LLC | 0.00% | New | 11,232 | $3K |
| St Germain D J Co. Inc. | 0.00% | New | 500 | $115 |
| Bogart Wealth, LLC | 0.00% | New | 34 | $8 |
"% of holder's portfolio" is BCLI's weight in each manager's 13F, not the share of Brainstorm Cell Therapeutics the manager owns.